Crinetics Pharmaceuticals (CRNX) Receivables - Accured (2018 - 2026)
Crinetics Pharmaceuticals' Receivables - Accured came in at $9.6 million for Q2 2026, up 14.3% from $8.4 million a year earlier and up 6.7% from the prior quarter.
Crinetics Pharmaceuticals (CRNX) Receivables - Accured (2018 - 2026) Analysis & Trends
At the end of FY2025, Crinetics Pharmaceuticals' Receivables - Accured was $7.8 million, down 6.1% from FY2024.
- Receivables - Accured carries a five-year compound annual growth rate of 133.2% (FY2020 to FY2025).
- Going back by year, Receivables - Accured was $8.31 million in FY2024 (+168.1%), $3.1 million in FY2023 (+121.4%), $1.4 million in FY2022 (+180.6%) and $499,000 in FY2021 (+341.6%).
- The Q2 2026 figure represents the highest quarterly Receivables - Accured in data going back to Q4 2018.
- Year-over-year, Receivables - Accured increased in seven of the last eight quarters, with growth averaging 73.3%.
- The fastest year-over-year change in Receivables - Accured over five years came in Q2 2022 (growth of 922.1%), and the weakest in Q3 2021 (a decline of 31.2%).
- Business Quant data shows CRNX's Receivables - Accured at $9 million (Q1 2026), $7.8 million (Q4 2025) and $6.34 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | - |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | - |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | Crinetics Pharmaceuticals | 8.99 Bn | 8.99 Bn | 24.96 Mn | 9.60 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.60 Mn |
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | 7.80 Mn |
| Sep 30, 2025 | 6.34 Mn |
| Jun 30, 2025 | 8.40 Mn |
| Mar 31, 2025 | 7.23 Mn |
| Dec 31, 2024 | 8.30 Mn |
| Sep 30, 2024 | 3.37 Mn |
| Jun 30, 2024 | 3.48 Mn |
| Mar 31, 2024 | 3.17 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | 2.62 Mn |
| Jun 30, 2023 | 897,000.00 |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2022 | 1.40 Mn |
| Jun 30, 2022 | 1.16 Mn |
| Mar 31, 2022 | 516,000.00 |
| Dec 31, 2021 | 499,000.00 |
| Sep 30, 2021 | 86,000.00 |
Crinetics Pharmaceuticals Receivables - Accured API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-accured&ticker=CRNX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-accured", "ticker": "CRNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables-accured&ticker=CRNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();